Page last updated: 2024-08-25

methylbenzoprim and methotrexate

methylbenzoprim has been researched along with methotrexate in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's1 (33.33)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Griffin, RJ; Meek, MA; Schwalbe, CH; Stevens, MF1
Griffin, RJ; Grunwaldt, JD; Lambert, PA; Meek, MA; Queener, SF; Robson, C; Schmidt, D1
Croughton, KA; Matthews, CS; Richardson, ML; Stevens, MF1

Other Studies

3 other study(ies) available for methylbenzoprim and methotrexate

ArticleYear
Structural studies on bioactive compounds. 8. Synthesis, crystal structure, and biological properties of a new series of 2,4-diamino-5-aryl-6-ethylpyrimidine dihydrofolate reductase inhibitors with in vivo activity against a methotrexate-resistant tumor c
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:11

    Topics: Animals; Antineoplastic Agents; Chemical Phenomena; Chemistry; Crystallization; Folic Acid Antagonists; Leukemia, Experimental; Liver; Methotrexate; Mice; Molecular Structure; Pyrimidines; Rats; Structure-Activity Relationship; Tumor Cells, Cultured

1989
Nonclassical 2,4-diamino-5-aryl-6-ethylpyrimidine antifolates: activity as inhibitors of dihydrofolate reductase from Pneumocystis carinii and Toxoplasma gondii and as antitumor agents.
    Journal of medicinal chemistry, 1997, Sep-12, Volume: 40, Issue:19

    Topics: Animals; Antineoplastic Agents; Cell Survival; Folic Acid Antagonists; Indicators and Reagents; Kinetics; Liver; Lymphoma, Large B-Cell, Diffuse; Mice; Pneumocystis; Pyrimidines; Rats; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Toxoplasma

1997
Structural studies on bioactive compounds. 39. Biological consequences of the structural modification of DHFR-inhibitory 2,4-diamino-6-(4-substituted benzylamino-3-nitrophenyl)-6-ethylpyrimidines ('benzoprims').
    Journal of medicinal chemistry, 2004, Jul-29, Volume: 47, Issue:16

    Topics: Antineoplastic Agents; Benzylamines; Cell Division; Cell Line, Tumor; Cyclization; Drug Screening Assays, Antitumor; Folic Acid Antagonists; Humans; Protein Binding; Pyrimidines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase

2004